Rodney M. Camire, Ph.D.

Dr. Camire is Assistant Professor of Pediatrics, The Children's Hospital of Philadelphia, and The University of Pennsylvania, School of Medicine.

Within the past 12 months, Dr. Camire has received research support from Novo Nordisk and has been a consultant for Bayer Healthcare.

Release Date: 04/16/2007
Termination Date: 04/16/2010

Estimated time to complete: 1 hour(s).

Albert Einstein College of Medicine designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Albert Einstein College of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Upon completion of this Cyberounds^®, the participant should be able to:

• Discuss the role of factor VIII and factor IX in hemostasis
• Describe the basic elements of the factor VIII and factor IX genes
• Describe the underlying genetic causes of hemophilia
• Describe currently available treatment regimens for hemophilia
• Describe future therapeutic strategies to treat hemophilia A and B.

 

This conference may include discussion of commercial products and services.

The opinions expressed herein are those of the authors and do not necessarily represent the views of the sponsor or its publisher. Please review complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.

 

Please click below to accept the terms of this CME activity